Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients
Int J Dermatol
.
2021 Sep;60(9):e382.
doi: 10.1111/ijd.15524.
Epub 2021 Mar 14.
Authors
Yu Wang
1
,
Joseph Jorizzo
2
3
Affiliations
1
SUNY Stonybrook Medical School, Stonybrook, NY, USA.
2
Department of Dermatology, Wake Forest University, Wake Frost, NC, USA.
3
Department of Dermatology, Weill Cornell Medicine, New York, NY, USA.
PMID:
33715168
DOI:
10.1111/ijd.15524
No abstract available
Publication types
Letter
MeSH terms
Antibodies, Monoclonal, Humanized / adverse effects
Asthma* / drug therapy
Dermatitis, Atopic* / drug therapy
Eczema*
Humans
Substances
Antibodies, Monoclonal, Humanized
dupilumab